Collegium Pharmaceutical IPO Research Information

Collegium Pharmaceutical IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Collegium Pharmaceutical, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Collegium Pharmaceutical	COLL - NASDAQ	$12.00-$14.00	$12.00	$12.00	5.8 million	5/7/2015
Underwriter(s): Jefferies, Piper Jaffray
Co-Manager(s): Wells Fargo Securities, Needham & Company
Industry: Health Care
Filing(s): Filed 2015-04-02 Terms Added 2015-04-27

Collegium Pharmaceutical Quote & Chart - Click for current quote - COLL

About Collegium Pharmaceutical (adapted from Collegium Pharmaceutical prospectus):
They are a specialty pharmaceutical company developing and planning to commercialize next-generation abuse-deterrent products that incorporate our patented DETERx platform technology for the treatment of chronic pain and other diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "COLL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.